|
Enriched gene sets in HPGF-C18 group (FDR < 0.25)
|
|
HALLMARK_CHOLESTEROL_HOMEOSTASIS
|
24
|
0.87
|
2.21
|
0.00
|
|
HALLMARK_MTORC1_SIGNALING
|
59
|
0.60
|
1.99
|
0.02
|
|
HALLMARK_ANDROGEN_RESPONSE
|
20
|
0.56
|
1.87
|
0.02
|
|
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY
|
26
|
0.53
|
1.86
|
0.02
|
|
HALLMARK_MITOTIC_SPINDLE
|
49
|
0.71
|
1.88
|
0.02
|
|
RESPONSE_TO_DNA_DAMAGE_STIMULUS
|
38
|
0.69
|
1.89
|
0.02
|
|
KEGG_P53_SIGNALING_PATHWAY
|
20
|
0.69
|
1.89
|
0.02
|
|
LIPID_BIOSYNTHETIC_PROCESS
|
32
|
0.52
|
1.90
|
0.03
|
|
NUCLEOCYTOPLASMIC_TRANSPORT
|
20
|
0.69
|
1.83
|
0.03
|
|
KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
|
25
|
0.72
|
1.91
|
0.03
|
|
HALLMARK_INTERFERON_ALPHA_RESPONSE
|
31
|
0.59
|
1.81
|
0.03
|
|
M_PHASE
|
38
|
0.72
|
1.74
|
0.04
|
|
DNA_METABOLIC_PROCESS
|
65
|
0.59
|
1.75
|
0.04
|
|
CELL_CYCLE_PROCESS
|
62
|
0.69
|
1.75
|
0.04
|
|
HALLMARK_ADIPOGENESIS
|
39
|
0.47
|
1.73
|
0.04
|
|
DNA_REPAIR
|
26
|
0.72
|
1.75
|
0.04
|
|
CELL_CYCLE_GO_0007049
|
95
|
0.57
|
1.77
|
0.04
|
|
HALLMARK_APOPTOSIS
|
57
|
0.44
|
1.73
|
0.04
|
|
DNA_RECOMBINATION
|
15
|
0.80
|
1.75
|
0.04
|
|
CELL_CYCLE_PHASE
|
56
|
0.67
|
1.76
|
0.04
|
|
HALLMARK_INTERFERON_GAMMA_RESPONSE
|
63
|
0.48
|
1.77
|
0.05
|
|
CHROMOSOME_ORGANIZATION_AND_BIOGENESIS
|
24
|
0.63
|
1.78
|
0.05
|
|
NUCLEAR_TRANSPORT
|
21
|
0.66
|
1.77
|
0.05
|
|
RESPONSE_TO_ENDOGENOUS_STIMULUS
|
50
|
0.55
|
1.71
|
0.05
|
|
KEGG_CELL_CYCLE
|
45
|
0.73
|
1.70
|
0.05
|
|
MITOTIC_CELL_CYCLE
|
50
|
0.69
|
1.71
|
0.05
|
|
BIOCARTA_HIVNEF_PATHWAY
|
17
|
0.59
|
1.70
|
0.05
|
|
MICROTUBULE_BASED_PROCESS
|
25
|
0.62
|
1.70
|
0.05
|
|
HALLMARK_DNA_REPAIR
|
22
|
0.66
|
1.69
|
0.06
|
|
CELL_CYCLE_CHECKPOINT_GO_0000075
|
20
|
0.74
|
1.68
|
0.06
|
|
ESTABLISHMENT_OF_CELLULAR_LOCALIZATION
|
71
|
0.42
|
1.66
|
0.07
|
|
KEGG_OOCYTE_MEIOSIS
|
31
|
0.56
|
1.66
|
0.07
|
|
GAMETE_GENERATION
|
37
|
0.47
|
1.66
|
0.07
|
|
PROTEIN_TARGETING
|
22
|
0.59
|
1.64
|
0.07
|
|
ESTABLISHMENT_OF_PROTEIN_LOCALIZATION
|
40
|
0.47
|
1.63
|
0.07
|
|
KEGG_APOPTOSIS
|
21
|
0.53
|
1.64
|
0.07
|
|
HALLMARK_G2M_CHECKPOINT
|
68
|
0.78
|
1.64
|
0.07
|
|
M_PHASE_OF_MITOTIC_CELL_CYCLE
|
26
|
0.75
|
1.64
|
0.07
|
|
MACROMOLECULE_LOCALIZATION
|
47
|
0.47
|
1.64
|
0.07
|
|
ORGANELLE_ORGANIZATION_AND_BIOGENESIS
|
118
|
0.41
|
1.62
|
0.07
|
|
REGULATION_OF_CELL_CYCLE
|
57
|
0.53
|
1.62
|
0.07
|
|
MITOSIS
|
26
|
0.75
|
1.64
|
0.07
|
|
CELLULAR_LOCALIZATION
|
74
|
0.41
|
1.61
|
0.08
|
|
DNA_DEPENDENT_DNA_REPLICATION
|
15
|
0.70
|
1.61
|
0.08
|
|
PROTEIN_TRANSPORT
|
35
|
0.47
|
1.60
|
0.08
|
|
CYTOSKELETON_ORGANIZATION_AND_BIOGENESIS
|
71
|
0.40
|
1.58
|
0.10
|
|
DNA_REPLICATION
|
26
|
0.63
|
1.58
|
0.10
|
|
KEGG_PEROXISOME
|
21
|
0.46
|
1.57
|
0.10
|
|
CELL_MIGRATION
|
26
|
0.43
|
1.56
|
0.11
|
|
HALLMARK_ESTROGEN_RESPONSE_EARLY
|
63
|
0.40
|
1.56
|
0.11
|
|
PROTEIN_LOCALIZATION
|
42
|
0.46
|
1.56
|
0.11
|
|
DETECTION_OF_STIMULUS
|
19
|
0.55
|
1.55
|
0.11
|
|
HALLMARK_IL2_STAT5_SIGNALING
|
59
|
0.37
|
1.54
|
0.12
|
|
INTRACELLULAR_PROTEIN_TRANSPORT
|
30
|
0.49
|
1.53
|
0.12
|
|
INTERPHASE
|
22
|
0.60
|
1.53
|
0.12
|
|
CELL_PROLIFERATION_GO_0008283
|
185
|
0.34
|
1.53
|
0.12
|
|
HALLMARK_E2F_TARGETS
|
60
|
0.72
|
1.52
|
0.13
|
|
INTERPHASE_OF_MITOTIC_CELL_CYCLE
|
19
|
0.61
|
1.51
|
0.13
|
|
SEXUAL_REPRODUCTION
|
48
|
0.46
|
1.51
|
0.13
|
|
ORGAN_MORPHOGENESIS
|
54
|
0.37
|
1.50
|
0.14
|
|
ANATOMICAL_STRUCTURE_MORPHOGENESIS
|
118
|
0.33
|
1.50
|
0.14
|
|
HALLMARK_UV_RESPONSE_UP
|
49
|
0.37
|
1.49
|
0.15
|
|
KEGG_PYRIMIDINE_METABOLISM
|
22
|
0.55
|
1.48
|
0.16
|
|
NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS
|
263
|
0.34
|
1.48
|
0.16
|
|
RESPONSE_TO_STRESS
|
140
|
0.32
|
1.46
|
0.17
|
|
TRANSLATION
|
30
|
0.42
|
1.46
|
0.17
|
|
HALLMARK_SPERMATOGENESIS
|
47
|
0.45
|
1.45
|
0.18
|
|
ACTIN_CYTOSKELETON_ORGANIZATION_AND_BIOGENESIS
|
38
|
0.36
|
1.45
|
0.18
|
|
KEGG_BASAL_CELL_CARCINOMA
|
16
|
0.47
|
1.41
|
0.22
|
|
HALLMARK_TNFA_SIGNALING_VIA_NFKB
|
69
|
0.38
|
1.39
|
0.24
|
|
Enriched gene sets in FBS group (FDR < 0.25)
|
|
HALLMARK_GLYCOLYSIS
|
54
|
0.56
|
1.97
|
0.02
|
|
ACTIVATION_OF_MAPK_ACTIVITY
|
15
|
0.65
|
1.73
|
0.14
|
|
POSITIVE_REGULATION_OF_MAP_KINASE_ACTIVITY
|
17
|
0.63
|
1.72
|
0.14
|
|
KEGG_CELL_ADHESION_MOLECULES_CAMS
|
48
|
0.49
|
1.68
|
0.15
|
|
KEGG_ECM_RECEPTOR_INTERACTION
|
33
|
0.54
|
1.74
|
0.15
|
|
KEGG_FOCAL_ADHESION
|
61
|
0.43
|
1.66
|
0.16
|
|
HALLMARK_HYPOXIA
|
66
|
0.51
|
1.68
|
0.16
|
|
KEGG_TGF_BETA_SIGNALING_PATHWAY
|
25
|
0.55
|
1.68
|
0.17
|
|
EXTRACELLULAR_STRUCTURE_ORGANIZATION_AND_BIOGENESIS
|
16
|
0.73
|
1.74
|
0.18
|
|
FEMALE_PREGNANCY
|
21
|
0.59
|
1.75
|
0.23
|
|
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION
|
79
|
0.51
|
1.78
|
0.23
|
|
TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY
|
18
|
0.54
|
1.60
|
0.25
|
